Immunity to polyomavirus infection: the polyomavirus-mouse model
- PMID: 19505652
- PMCID: PMC2694952
- DOI: 10.1016/j.semcancer.2009.02.003
Immunity to polyomavirus infection: the polyomavirus-mouse model
Abstract
A ubiquitous clinically silent murine pathogen, polyomavirus has enjoyed long-term co-evolution with the mouse, a highly tractable and genetically and immunologically informative small animal model. Thus, polyomavirus has provided a valuable experimental construct to decipher the host immune mechanisms that come into play to control systemic low-level persistent viral infections. Impaired immunosurveillance for infected cells puts the murine host at risk both to injury resulting from excessive direct virus cytolysis and development of virus-induced tumors. In this review, we present our current understanding of the multifaceted immune response invoked by the mouse to maintain détente with this potentially deleterious persistent natural pathogen, and discuss implications of these studies for therapeutic interventions for human polyomavirus infection.
References
-
- Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med. 1953;83:414–21. - PubMed
-
- Stewart SE, Eddy BE, Gochenour AM, Borgese NG, Grubbs GE. Leukemia in mice produced by a filterable agent present in AKR leukemic tissues with notes on a sarcoma produced by the same agent. Anat Record. 1953;117:532.
-
- Talmage DA, Freund R, Dubensky T, Salcedo M, Gariglio P, Rangel LM, et al. Heterogeneity in state and expression of viral DNA in polyoma virus- induced tumors of the mouse. Virology. 1992;187:734–47. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
